Hui-Ling Qu (Huiling Qu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Antiplatelet Therapy

Genome Wide Association

Magnetic Resonance

Mild Cognitive Impairment

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao-Yu Sun, Chao He, Shida Yang, Weizhuo Li, Hui-Ling Qu
Mendelian randomization to evaluate the effect of folic acid supplement on the risk of Alzheimer disease. Medicine 103 (6) (2024)
Xiao-Yu Sun, Chao He, Shida Yang, Weizhuo Li, Hui-Ling Qu
Mendelian randomization to evaluate the effect of folic acid supplement on the risk of Alzheimer disease. Medicine 103 (6) (2024)
Hui-Ling Qu, Xiao-Yu Sun, Chao He, Hui-Sheng Chen
Sex Differences in the Dual Antiplatelet Therapy Versus Alteplase for Patients with Minor Nondisabling Acute Ischemic Stroke: A Secondary Analysis of the ARAMIS Study. CNS drugs (2024)
Hui-Ling Qu, Xiao-Yu Sun, Chao He, Hui-Sheng Chen
Sex Differences in the Dual Antiplatelet Therapy Versus Alteplase for Patients with Minor Nondisabling Acute Ischemic Stroke: A Secondary Analysis of the ARAMIS Study. CNS drugs 38 (8) (2024)
Xiaoyu Sun, Chao He, Hui-Ling Qu
Bibliometric review on sleep and Alzheimer disease between 1986 and 2023. Medicine 102 (44) (2023)
Xiaojie Yang, Hui-Ling Qu
Bibliometric review on biomarkers for Alzheimer's disease between 2000 and 2023. Medicine 102 (36) (2023)
Hui-Ling Qu, Chao He, Haichun Xu, Xiao-Yu Sun
Investigating the association of breast cancer and stroke: A two-sample Mendelian randomization study. Medicine 102 (38) (2023)